Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Global Bioenergies stock price, quote, forecast and news

ALGBE.PA
FR0011052257
A1JBVH

Price

1.42
Today +/-
-0.03
Today %
-2.23 %
P

Global Bioenergies stock price

%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the Global Bioenergies stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Global Bioenergies stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Global Bioenergies stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Global Bioenergies's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Global Bioenergies Stock Price History

DateGlobal Bioenergies Price
9/27/20241.42 undefined
9/26/20241.45 undefined
9/25/20241.45 undefined
9/24/20241.46 undefined
9/23/20241.48 undefined
9/20/20241.45 undefined
9/19/20241.48 undefined
9/18/20241.48 undefined
9/17/20241.53 undefined
9/16/20241.55 undefined
9/13/20241.56 undefined
9/12/20241.62 undefined
9/11/20241.61 undefined
9/10/20241.73 undefined
9/9/20241.71 undefined
9/6/20241.69 undefined
9/5/20241.67 undefined
9/4/20241.67 undefined
9/3/20241.70 undefined
9/2/20241.70 undefined

Global Bioenergies Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Global Bioenergies, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Global Bioenergies from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Global Bioenergies’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Global Bioenergies. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Global Bioenergies’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Global Bioenergies’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Global Bioenergies’s growth potential.

Global Bioenergies Revenue, EBIT and net profit per share

DateGlobal Bioenergies RevenueGlobal Bioenergies EBITGlobal Bioenergies Net Income
2026e7.11 M undefined-10.47 M undefined-8.6 M undefined
2025e6.95 M undefined-7.93 M undefined-4.39 M undefined
2024e5.87 M undefined-7.36 M undefined-5.32 M undefined
20233.25 M undefined-9.47 M undefined-8.66 M undefined
2022697,540 undefined-13.19 M undefined-11.99 M undefined
2021100,940 undefined-13.35 M undefined-11.77 M undefined
202063,850 undefined-13.49 M undefined-11.15 M undefined
2019117,470 undefined-14.02 M undefined-12.74 M undefined
2018692,040 undefined-15.68 M undefined-13.64 M undefined
2017306,300 undefined-15.63 M undefined-14.25 M undefined
2016536,300 undefined-11.92 M undefined-10.61 M undefined
20151.36 M undefined-12.01 M undefined-10.39 M undefined
20141.79 M undefined-8.32 M undefined-6.26 M undefined
20131.16 M undefined-6.67 M undefined-5.13 M undefined
20121.78 M undefined-1.2 M undefined-250,000 undefined
2011150,000 undefined-3.95 M undefined-3.5 M undefined
20100 undefined-2.43 M undefined-2.03 M undefined
20090 undefined-1.57 M undefined-1.3 M undefined
20080 undefined-340,000 undefined-240,000 undefined

Global Bioenergies Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20082009201020112012201320142015201620172018201920202021202220232024e2025e2026e
0000111100000003567
----------------66.6720.0016.67
------500.00-400.00-700.00--------133.33---
00-1-20-5-4-7-9-10-8-8-8-10-7-4000
0-1-2-3-1-6-8-12-11-15-15-14-13-13-13-9-7-7-10
-----100.00-600.00-800.00-1,200.00--------300.00-140.00-116.67-142.86
0-1-2-30-5-6-10-10-14-13-12-11-11-11-8-5-4-8
--100.0050.00--20.0066.67-40.00-7.14-7.69-8.33---27.27-37.50-20.00100.00
1.251.251.571.651.822.762.782.823.354.555.178.8610.2915.115.2218.03000
-------------------
Details

Keystats

Revenue and Growth

The Global Bioenergies Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Global Bioenergies is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (k)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (k)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (k)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
2008200920102011201220132014201520162017201820192020202120222023
                               
0.320.095.754.096.2923.6815.4710.428.0713.6410.7616.8714.8521.088.9411.84
000.080.081.1701.170.380.170.020.060.060.10.020.080.02
000.710.631.091.743.062.914.143.693.613.234.713.513.572.23
00.030.060.110.110.150.290.30.330.380.60.631.972.042.590.57
204070410200140333.39722.26430.38412.52352.15342.09283.46261.37300.15378.3
0.340.166.675.328.8625.7120.3214.7313.1418.1415.3721.1321.9126.9115.4815.04
0.020.110.120.380.390.562.17.2312.1811.087.784.531.692.534.012.55
0.010.030.040.080.080.121.460.140.150.371.061.071.211.541.550.34
00000000000001.772.140
0.010.010.010.0100.080.140.110.071.271.231.230.980.81.251.28
00000000000000-0.72-0.95
0000000000000000
0.040.150.170.470.470.763.697.4812.412.7110.076.823.886.658.243.22
0.380.316.845.799.3326.4724.0222.2125.5430.8525.4427.9525.833.5623.7218.25
                               
4050808090140138.77141.51167.68224.38253.97435.95506.62743.29749.43906.44
0.61.29.110.513.2634.9536.0137.8249.4167.8774.2190.3596.0229.2916.0310.54
-0.24-1.54-3.12-6.63-6.88-12.01-18.27-30.06-40.67-54.93-68.56-81.29-92.44-16.47-14.69-11.43
000000000.390.550.380.210.045.15.5610.39
0000000000000000
0.4-0.296.063.956.4723.0817.887.99.313.726.289.714.1318.667.6510.41
0.050.230.240.960.870.682.123.184.124.623.362.642.73.525.582.41
0.080.120.150.220.230.380.570.660.60.720.931.091.360.310.210.22
000.0101.751.61.245.126.988.7813.0713.3711.834.13.121.46
006000000125.81138.12226.552.332.58000
000000001.381.27000000
0.130.350.461.182.852.663.938.9613.2115.5317.5817.115.897.938.924.09
00.330.330.6600.742.215.322.991.541.510.955.595.134.93.71
0000000000000000
000000029.8542.0456.8965.67191.87183.2660.79109.7753.36
00.330.330.6600.742.215.353.041.61.571.145.775.195.013.76
0.130.680.791.842.853.46.1314.3116.2417.1319.1618.2421.6713.1213.937.85
0.530.396.855.799.3226.4824.0222.2125.5430.8525.4427.9525.831.7921.5818.25
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Global Bioenergies provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Global Bioenergies's financial health and stability.

Assets

Global Bioenergies's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Global Bioenergies must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Global Bioenergies after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Global Bioenergies's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2008200920102011null20122013201420152016201720182019202020212022
0-1-1-3-30-5-7-10-10-14-13-12-11-11-11
0000000001233310
0000000000000000
0000000-100220-2-11
0000000000000000
0000000000000000
0000000000000000
0-1-2-2-20-4-8-8-9-9-7-10-10-11-10
00000000-4-6-2000-2-1
0000000-2-4-6-2000-2-1
0000000-200000000
0000000000000000
0000000060-101300
0081132323112176165210
007112222712165179210
000000-1200000000
0000000000000000
005-1-1217-8-5-25-36-16-12
-0.32-1.16-2.41-3.50-1.16-5.38-8.84-13.33-15.4-11.09-8.39-10.51-11.29-14.72-12.1
0000000000000000

Global Bioenergies stock margins

The Global Bioenergies margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Global Bioenergies. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Global Bioenergies.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Global Bioenergies's sales revenue. A higher gross margin percentage indicates that the Global Bioenergies retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Global Bioenergies's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Global Bioenergies's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Global Bioenergies's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Global Bioenergies. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Global Bioenergies's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Global Bioenergies Margin History

Global Bioenergies Gross marginGlobal Bioenergies Profit marginGlobal Bioenergies EBIT marginGlobal Bioenergies Profit margin
2026e-153.2 %-147.27 %-120.97 %
2025e-153.2 %-114.07 %-63.11 %
2024e-153.2 %-125.44 %-90.64 %
2023-153.2 %-291.53 %-266.41 %
2022-1,143.14 %-1,891.16 %-1,718.38 %
2021-9,911.24 %-13,223.62 %-11,663.38 %
2020-13,561.05 %-21,134.47 %-17,459.95 %
2019-7,229.37 %-11,938 %-10,846.43 %
2018-1,249.17 %-2,265.22 %-1,970.51 %
2017-3,324.54 %-5,104.03 %-4,653.35 %
2016-1,769.23 %-2,223.31 %-1,977.83 %
2015-554.43 %-881.05 %-762.37 %
2014-271.61 %-463.89 %-348.98 %
2013-448.28 %-575 %-442.24 %
2012-1.69 %-67.42 %-14.04 %
2011-1,460 %-2,633.33 %-2,333.33 %
2010-153.2 %0 %0 %
2009-153.2 %0 %0 %
2008-153.2 %0 %0 %

Global Bioenergies Stock Sales Revenue, EBIT, Earnings per Share

The Global Bioenergies earnings per share therefore indicates how much revenue Global Bioenergies has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Global Bioenergies earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Global Bioenergies's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Global Bioenergies’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Global Bioenergies's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Global Bioenergies Revenue, EBIT and net profit per share

DateGlobal Bioenergies Sales per ShareGlobal Bioenergies EBIT per shareGlobal Bioenergies Earnings per Share
2026e0.39 undefined0 undefined-0.47 undefined
2025e0.38 undefined0 undefined-0.24 undefined
2024e0.32 undefined0 undefined-0.29 undefined
20230.18 undefined-0.53 undefined-0.48 undefined
20220.05 undefined-0.87 undefined-0.79 undefined
20210.01 undefined-0.88 undefined-0.78 undefined
20200.01 undefined-1.31 undefined-1.08 undefined
20190.01 undefined-1.58 undefined-1.44 undefined
20180.13 undefined-3.03 undefined-2.64 undefined
20170.07 undefined-3.43 undefined-3.13 undefined
20160.16 undefined-3.56 undefined-3.17 undefined
20150.48 undefined-4.25 undefined-3.68 undefined
20140.65 undefined-3 undefined-2.25 undefined
20130.42 undefined-2.42 undefined-1.86 undefined
20120.98 undefined-0.66 undefined-0.14 undefined
20110.09 undefined-2.39 undefined-2.12 undefined
20100 undefined-1.55 undefined-1.29 undefined
20090 undefined-1.26 undefined-1.04 undefined
20080 undefined-0.27 undefined-0.19 undefined

Global Bioenergies business model

Global Bioenergies SA is a French company that was founded in 2008 to create alternative energy sources through the production of biomass. The company's main goal is to create a sustainable and low-carbon energy source that reduces dependence on non-renewable resources. Global Bioenergies is involved in the development of technologies for the production of biofuels and biogas from renewable resources. The company's business model is based on the production of biomass through the fermentation of sugar from plant waste, industrial residues, and CO2. The production of biomass can be directly converted into biofuels such as ethanol and butanol. Additionally, the biogas produced during the fermentation of biomass can be used for electricity generation or as a raw material for chemical products. Global Bioenergies has divided its business activities into various segments focusing on different products and technologies. One important segment is the development of biomass production technologies based on sugar fermentation. Global Bioenergies' technology allows for the production of sugar from a variety of sources such as corn, straw, wood waste, and cellulose. Another important segment of the company is the development of biofuel production technologies. Global Bioenergies has developed a modular biofuel production plant that enables the production of a wide range of biofuels such as butanol, isobutene, ethanol, and propylene from a single feedstock. The company has already begun testing and pilot production to experiment and further develop the technology. An important area of focus for Global Bioenergies is the development of bio-based molecules that can be used as raw materials in various industries. The company is working on the development of bio-based molecules that can be used in the cosmetics industry, pharmaceutical industry, or in the production of plastics. One example is bio-based isobutene, which can serve as a raw material for rubber and plastics. Global Bioenergies is also involved in the development of biogas and renewable hydrogen. The company has developed a technology for hydrogen production through the photolysis of water, which directly utilizes sunlight to split water into hydrogen and oxygen. Additionally, the company has developed a technology that enables the production of biogas from organic waste such as yard trimmings, food waste, and animal excrement. Global Bioenergies aims to create a sustainable energy source that meets the growing energy demand without burdening the environment. The company continuously works on improving its technologies and products to move closer to the vision of a CO2-neutral, sustainable energy infrastructure. With its innovative technologies, dedicated research, and vision, Global Bioenergies has become a key player in the renewable energy sector. Global Bioenergies is one of the most popular companies on Eulerpool.com.

Global Bioenergies SWOT Analysis

Strengths

Global Bioenergies SA has developed innovative technology for converting renewable resources into valuable chemicals.

The company has established strong partnerships with leading companies in the energy, transportation, and chemical industries.

Global Bioenergies SA has a diversified feedstock base, reducing dependency on any single resource.

Weaknesses

As a relatively young company, Global Bioenergies SA may face limited brand recognition and market presence compared to established competitors.

The company's technology is still in the development phase and may require further research and testing before commercialization.

Global Bioenergies SA's financial stability can be a challenge as it requires significant investment to scale up operations and commercialize its technology.

Opportunities

Growing global demand for sustainable alternatives to fossil fuels and petrochemicals presents a significant opportunity for Global Bioenergies SA.

The company can capitalize on increasing government regulations and incentives favoring renewable energy and green technologies.

Expanding into new geographical markets and industries can help Global Bioenergies SA to diversify its customer base.

Threats

Intense competition from well-established players in the biofuels and renewable chemicals industry poses a threat to Global Bioenergies SA's market share.

Volatility in the prices of feedstock resources may impact the company's profitability and operational costs.

Global Bioenergies SA may face regulatory challenges and obstacles in obtaining necessary approvals, permits, and certifications for its technology and products.

Global Bioenergies Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Global Bioenergies historical P/E ratio, EBIT, and P/S ratio.

Global Bioenergies shares outstanding

The number of shares was Global Bioenergies in 2023 — This indicates how many shares 18.034 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Global Bioenergies earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Global Bioenergies's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Global Bioenergies’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Global Bioenergies's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Global Bioenergies.

Global Bioenergies list of shareholders

%
Name
Stocks
Change
Date
2.52612 % Delcourt (Marc)457,92177,5796/30/2023
13.22783 % L'Oreal SA2,397,871425,6656/30/2023
1.01239 % La Française AM183,520012/31/2023
0.29534 % HSBC Global Asset Management (France) S.A.53,538010/31/2023
0.23107 % Global Bioenergies Employees41,88841,88812/31/2022
0.05516 % Myria Asset Management10,00010,0001/31/2023
0 % Mirova0-114,5086/30/2023
0 % Amiral Gestion S.A.0-181,0183/31/2023
0 % DNCA Investments0-101,93312/31/2022
0 % Financière Arbevel0-128,6066/30/2023
1
2

Global Bioenergies Executives and Management Board

Dr. Marc Delcourt52
Global Bioenergies Chief Executive Officer, Director (since 2009)
Compensation 193,750
Ms. Corinne Granger65
Global Bioenergies Chairman of the Board (since 2020)
Compensation 67,050
Mr. Pierre Monsan74
Global Bioenergies Independent Director
Compensation 24,900
Mr. Pierre Levi68
Global Bioenergies Independent Director, Representative of Metman Capital
Compensation 20,700
Ms. Marie- Odile Lavenant57
Global Bioenergies Independent Director, Representative of Botheia
Compensation 6,000
1
2
3

Global Bioenergies Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
SupplierCustomer0,480,840,650,250,160,25
1

Most common questions regarding Global Bioenergies

What values and corporate philosophy does Global Bioenergies represent?

Global Bioenergies SA is a leading company in the field of renewable fuels and chemicals. With a strong commitment to sustainability and innovation, the company aims to transform the energy industry by developing and commercializing advanced biofuels derived from non-food biomass. Global Bioenergies SA values environmental responsibility, aiming to reduce greenhouse gas emissions and promote a cleaner future. With a corporate philosophy centered around technological excellence and collaboration, Global Bioenergies SA strives to revolutionize the energy sector, offering sustainable alternatives with the potential to reshape the way we power our world.

In which countries and regions is Global Bioenergies primarily present?

Global Bioenergies SA is primarily present in several countries and regions worldwide. The company has a strong presence in France, where its headquarters are located. It also operates in Germany, where it has established a subsidiary. Additionally, Global Bioenergies SA has a growing presence in the United States, with ongoing partnerships and collaborations. The company is actively expanding its reach into other European countries, including Spain and the Netherlands, to establish a robust international footprint. With its innovative bio-based processes and technologies, Global Bioenergies SA is continuously broadening its global presence to drive sustainable solutions in the field of renewable energies.

What significant milestones has the company Global Bioenergies achieved?

Global Bioenergies SA has achieved several significant milestones. One of its major achievements includes the successful production of renewable isobutene, a key building block for various sustainable products. The company has also developed a robust portfolio of partnerships and collaborations with renowned companies in the energy and chemical sectors. Furthermore, Global Bioenergies SA has made substantial progress in scaling up its proprietary bioconversion process, showcasing its commitment to commercialization. These accomplishments highlight Global Bioenergies SA's pioneering efforts in the field of renewable energy and its dedication to revolutionizing the bio-based industry.

What is the history and background of the company Global Bioenergies?

Global Bioenergies SA is a leading French biotechnology company specializing in renewable resources and the production of alternative fuels. Established in 2008, the company focuses on developing innovative processes to convert renewable resources into hydrocarbons through the use of fermentation. Global Bioenergies SA has achieved significant milestones, such as successfully producing isobutene, a key building block for various applications including biofuels and plastics. By leveraging its expertise in bio-based production, Global Bioenergies SA aims to contribute to reducing greenhouse gas emissions and promoting sustainable alternatives in the energy sector. This company has emerged as a key player in the field of renewable energy solutions.

Who are the main competitors of Global Bioenergies in the market?

The main competitors of Global Bioenergies SA in the market include companies like Amyris Inc., REG Life Sciences LLC, Gevo Inc., and LanzaTech Inc. These companies also specialize in the production and development of bio-based products and alternative fuels. However, Global Bioenergies SA stands out in the industry with its unique proprietary technology and strong focus on the commercialization of renewable hydrocarbons.

In which industries is Global Bioenergies primarily active?

Global Bioenergies SA is primarily active in the bioenergy industry. As a leading company in this sector, Global Bioenergies SA focuses on developing innovative solutions for the production of renewable fuels and chemicals. With their advanced biotechnology platform, they aim to reduce dependency on fossil resources and contribute to a more sustainable future. Global Bioenergies SA's expertise lies in the production of bio-based isobutene, a key ingredient in various applications including transportation fuels, plastics, and cosmetics. By harnessing the power of biology, Global Bioenergies SA is revolutionizing the energy and chemical industries with their environmentally friendly solutions.

What is the business model of Global Bioenergies?

The business model of Global Bioenergies SA is focused on developing and commercializing renewable carbon-based compounds. They utilize proprietary technology to convert renewable resources, such as agricultural and forestry waste, into high-performance products like biofuels and renewable chemicals. Through their innovative approach, Global Bioenergies aims to contribute to the transition towards a more sustainable and environmentally-friendly economy. By utilizing renewable resources, their business model helps reduce reliance on fossil fuels, lower greenhouse gas emissions, and promote the shift towards a circular economy.

What is the P/E ratio of Global Bioenergies 2024?

The Global Bioenergies P/E ratio is -4.8.

What is the P/S ratio of Global Bioenergies 2024?

The Global Bioenergies P/S ratio is 4.35.

What is the AlleAktien quality score of Global Bioenergies?

The AlleAktien quality score for Global Bioenergies is 5/10.

What is the revenue of Global Bioenergies 2024?

The expected Global Bioenergies revenue is 5.87 M EUR.

How high is the profit of Global Bioenergies 2024?

The expected Global Bioenergies profit is -5.32 M EUR.

What is the business model of Global Bioenergies

Global Bioenergies SA is a French company specializing in the development of technologies for renewable energy resources. Its business model is focused on reducing dependence on fossil fuels and instead transitioning to biofuels. The company operates in three main areas: biofuels, industrial chemicals, and food additives. In the biofuels sector, Global Bioenergies has developed an innovative process for converting renewable resources such as sugar or starch into isobutene. Isobutene is an important raw material for the production of biofuels and can be used as a substitute for conventional petroleum. Global Bioenergies has already found various partners who have recognized the potential of isobutene and are interested in its commercial use. For example, the company has entered into a strategic partnership with Audi to work together on the production of biofuels based on isobutene. In the industrial chemicals sector, Global Bioenergies has also developed a process for producing isobutene that can be used for the production of various chemicals. These chemicals are used in various industries, such as solvents or the production of plastics. Here too, the company has already formed partnerships to enable the commercial use of the technology. In the food additives sector, Global Bioenergies has developed a technology that allows for the production of certain flavorings for the food industry based on renewable resources. This technology can be used, for example, to produce vanilla extract. There is a strong interest in the use of renewable resources to meet the growing demand for flavors in the food industry. In addition to these three main areas, Global Bioenergies is also involved in research and development. The company invests in the further development of its technologies and works to expand them to other areas of application. Overall, Global Bioenergies has built a promising business model aimed at using renewable resources for the production of biofuels, industrial chemicals, and food additives. The company has already formed important partnerships and is on track to scale up its technologies commercially. By using renewable resources, Global Bioenergies contributes to reducing dependence on fossil fuels and making a significant contribution to climate protection.

What is the Global Bioenergies dividend?

Global Bioenergies pays a dividend of 0 EUR distributed over payouts per year.

How often does Global Bioenergies pay dividends?

The dividend cannot currently be calculated for Global Bioenergies or the company does not pay out a dividend.

What is the Global Bioenergies ISIN?

The ISIN of Global Bioenergies is FR0011052257.

What is the Global Bioenergies WKN?

The WKN of Global Bioenergies is A1JBVH.

What is the Global Bioenergies ticker?

The ticker of Global Bioenergies is ALGBE.PA.

How much dividend does Global Bioenergies pay?

Over the past 12 months, Global Bioenergies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Global Bioenergies is expected to pay a dividend of 0 EUR.

What is the dividend yield of Global Bioenergies?

The current dividend yield of Global Bioenergies is .

When does Global Bioenergies pay dividends?

Global Bioenergies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Global Bioenergies?

Global Bioenergies paid dividends every year for the past 0 years.

What is the dividend of Global Bioenergies?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Global Bioenergies located?

Global Bioenergies is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von Global Bioenergies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Global Bioenergies from 9/30/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 9/30/2024.

When did Global Bioenergies pay the last dividend?

The last dividend was paid out on 9/30/2024.

What was the dividend of Global Bioenergies in the year 2023?

In the year 2023, Global Bioenergies distributed 0 EUR as dividends.

In which currency does Global Bioenergies pay out the dividend?

The dividends of Global Bioenergies are distributed in EUR.

All fundamentals about Global Bioenergies

Our stock analysis for Global Bioenergies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Global Bioenergies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.